Ki‐67 showed a high expression rate (≥10%) in almost 80% of cases of high‐grade astrocytomas (WHO grade III/IV), which was remarkably higher (P < .001) than in cases of low‐grade tumors (WHO grade I/II). This evidence concerns the gene MKI67 and astrocytoma (excluding glioblastoma).